BioNTech Investor Day Presentation Deck
BioNTech today
مربع
ČC
Discovery powerhouse
>1,000 research and development professionals
IP portfolio with >200 patent families
>300 publications including >100 in leading peer
reviewed journals
Diversified pipeline across 4 drug
classes
21 clinical trials
17 product candidates in clinical development
World-class partners
Pfizer, Genentech, Genmab, Regeneron, Fosun, Sanofi,
Crescendo, Medigene, InstaDeep, TRON, BMGF, UPenn
and multiple not-for-profit organizations
ဝဂ္ဂီ
-O
Global organization on 3 continents
>3,300 employees
>60 nationalities
Presence in Europe, United States and Asia
Diversified GMP manufacturing
infrastructure
2 state-of-the-art cGMP cell therapy sites
Global commercial scale mRNA production
Initial commercial team in Germany
Strong shareholder base, fortress
balance sheet
>€18bn in cash equivalents and trade receivables
as end of Q1 22
BIONTECH
11View entire presentation